Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity
暂无分享,去创建一个
M. Vogel | M. Bachmann | A. Wallimann | Mona O. Mohsen | L. Zha | Xuelan Liu | Pascal S. Krenger | Xinyue Chang
[1] M. Vogel,et al. A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut Allergy , 2020, International Archives of Allergy and Immunology.
[2] M. Vogel,et al. Vaccine against peanut allergy based on engineered Virus-Like-Particles displaying single major peanut allergens. , 2019, The Journal of allergy and clinical immunology.
[3] Y. Ohya,et al. Trajectories of class–switching‐related egg and cow's milk allergen‐specific immunoglobulin isotype formation and its modification by eczema with low‐ and high‐affinity immunoglobulin E during early infancy , 2019, Immunity, inflammation and disease.
[4] L. Reber,et al. Approaches to target IgE antibodies in allergic diseases. , 2018, Pharmacology & therapeutics.
[5] A. Murphy,et al. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement , 2018, Nature Communications.
[6] M. Vogel,et al. An unexpected protective role of low‐affinity allergen‐specific IgG through the inhibitory receptor Fc&ggr;RIIb , 2018, The Journal of allergy and clinical immunology.
[7] J. Konradsen,et al. [Allergen-specific immunotherapy provides long-lasting symptom relief]. , 2016, Lakartidningen.
[8] M. Vogel,et al. High affinity targeting of CD23 inhibits IgE synthesis in human B cells , 2015, Immunity, inflammation and disease.
[9] Ayfer Yukselen,et al. Role of immunotherapy in the treatment of allergic asthma. , 2014, World journal of clinical cases.
[10] T. Kündig,et al. IgG‐mediated down‐regulation of IgE bound to mast cells: a potential novel mechanism of allergen‐specific desensitization , 2014, Allergy.
[11] Stephen J Galli,et al. IgE and mast cells in allergic disease , 2012, Nature Medicine.
[12] B. Ozanne,et al. CD23/FcεRII: molecular multi‐tasking , 2010, Clinical and experimental immunology.
[13] T. Kündig,et al. Mechanisms of allergen-specific desensitization. , 2010, The Journal of allergy and clinical immunology.
[14] D. Metcalfe,et al. Mechanisms of mast cell signaling in anaphylaxis. , 2009, The Journal of allergy and clinical immunology.
[15] D. Miklavčič,et al. The temperature effect during pulse application on cell membrane fluidity and permeabilization. , 2008, Bioelectrochemistry.
[16] E. Riise,et al. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. , 2008, The Journal of allergy and clinical immunology.
[17] B. Sutton,et al. IgE in allergy and asthma today , 2008, Nature Reviews Immunology.
[18] D. Conrad,et al. CD23: An overlooked regulator of allergic disease , 2007, Current allergy and asthma reports.
[19] C. Akdis,et al. Immunological mechanisms of allergen-specific immunotherapy , 2006, Nature Reviews Immunology.
[20] F. Finkelman,et al. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking , 2006 .
[21] M. Blumenthal,et al. Evidence of an affinity threshold for IgE‐allergen binding in the percutaneous skin test reaction , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[22] G. Watt,et al. Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring , 2000, BMJ : British Medical Journal.
[23] H. Metzger,et al. An unusual mechanism for ligand antagonism. , 1998, Science.
[24] G. Köhler,et al. Negative feedback regulation of IgE synthesis by murine CD23 , 1994, Nature.